BR9713522A - Método de uso de inibidores da cicloxigenase-2 como agentes antiangiogênicos. - Google Patents
Método de uso de inibidores da cicloxigenase-2 como agentes antiangiogênicos.Info
- Publication number
- BR9713522A BR9713522A BR9713522A BR9713522A BR9713522A BR 9713522 A BR9713522 A BR 9713522A BR 9713522 A BR9713522 A BR 9713522A BR 9713522 A BR9713522 A BR 9713522A BR 9713522 A BR9713522 A BR 9713522A
- Authority
- BR
- Brazil
- Prior art keywords
- cyclooxygenase
- inhibitors
- antiangiogenic agents
- antiangiogenic
- agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3140496P | 1996-11-19 | 1996-11-19 | |
PCT/US1997/021489 WO1998022101A2 (fr) | 1996-11-19 | 1997-11-19 | Procede d'utilisation d'inhibiteurs de cyclo-oxygenase-2 comme agents anti-angiogeniques |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9713522A true BR9713522A (pt) | 2000-03-21 |
Family
ID=21859277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9713522A BR9713522A (pt) | 1996-11-19 | 1997-11-19 | Método de uso de inibidores da cicloxigenase-2 como agentes antiangiogênicos. |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0941080A2 (fr) |
JP (1) | JP2001505564A (fr) |
KR (1) | KR20000053362A (fr) |
CN (1) | CN1247470A (fr) |
AU (1) | AU730211B2 (fr) |
BR (1) | BR9713522A (fr) |
CA (1) | CA2270469C (fr) |
CZ (1) | CZ176899A3 (fr) |
ID (1) | ID21979A (fr) |
IL (1) | IL129604A (fr) |
NO (1) | NO992309L (fr) |
NZ (1) | NZ335853A (fr) |
PL (2) | PL194717B1 (fr) |
RO (1) | RO118566B1 (fr) |
RU (1) | RU2268716C2 (fr) |
SK (1) | SK59999A3 (fr) |
TR (1) | TR199901703T2 (fr) |
UA (1) | UA70294C2 (fr) |
WO (1) | WO1998022101A2 (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6515014B2 (en) | 1995-06-02 | 2003-02-04 | G. D. Searle & Co. | Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
US6512121B2 (en) | 1998-09-14 | 2003-01-28 | G.D. Searle & Co. | Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
US6887893B1 (en) | 1997-12-24 | 2005-05-03 | Sankyo Company, Limited | Methods and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia |
CN1346282A (zh) * | 1998-12-23 | 2002-04-24 | G.D.西尔公司 | 在肿瘤的治疗中使用环加氧酶-2-抑制剂与一种或多种抗肿瘤剂作为联合治疗的方法 |
US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
US20030013739A1 (en) * | 1998-12-23 | 2003-01-16 | Pharmacia Corporation | Methods of using a combination of cyclooxygenase-2 selective inhibitors and thalidomide for the treatment of neoplasia |
DE60023119T2 (de) * | 1999-03-10 | 2006-07-20 | G.D. Searle Llc | Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere |
DK1206256T3 (da) * | 1999-07-29 | 2005-08-15 | Amgen Inc | Kombinationsbehandling under anvendelse af pentafluorbenzensulfonamid og platinforbindelse |
PT1282418E (pt) * | 2000-05-19 | 2005-10-31 | Applied Research Systems | Utilizacao de derivados pirazolo para o tratamento da infertilidade |
US6822001B2 (en) | 2000-11-03 | 2004-11-23 | Tularik Inc. | Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents |
KR100686537B1 (ko) * | 2001-12-28 | 2007-02-27 | 씨제이 주식회사 | 사이클로옥시게나제-2 의 저해제로서 선택성이 뛰어난디아릴 1,2,4-트리아졸 유도체 |
MXPA05000722A (es) * | 2002-07-17 | 2005-04-08 | Warner Lambert Co | Combinacion de un inhibidor alosterico carboxilico de la metaloproteinasa-13 de la matriz con un inhibidor selectivo de la ciclooxigenasa-2 que no es celecoxib o valdecoxib. |
KR100484525B1 (ko) * | 2002-10-15 | 2005-04-20 | 씨제이 주식회사 | 이소티아졸 유도체, 그 제조방법 및 약제학적 조성물 |
AT504159A1 (de) * | 2006-08-16 | 2008-03-15 | Marlyn Nutraceuticals Inc | Verwendung von proteasen |
RU2475257C1 (ru) * | 2011-06-22 | 2013-02-20 | Людмила Николаевна Третьяк | Средство для повышения адаптируемости организма к экстремальным условиям |
GB2496135B (en) * | 2011-11-01 | 2015-03-18 | Valirx Plc | Inhibitors of the interaction between a Src family kinase and an androgen receptor or estradiol receptor for treatment of endometriosis |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0759432A1 (fr) * | 1993-01-15 | 1997-02-26 | G.D. Searle & Co. | Utilisation de médicaments contenant des furannes 3,4-diaryles et leurs analogues pour le traitement des conditions de la peau |
US5436265A (en) * | 1993-11-12 | 1995-07-25 | Merck Frosst Canada, Inc. | 1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents |
DK0924201T3 (da) * | 1993-11-30 | 2002-05-21 | Searle & Co | Tricyclisk substitueret pyrazolylbenzensulfonamider og deres anvendelse som cyclooxygenase II-inhibitorer |
US5521213A (en) * | 1994-08-29 | 1996-05-28 | Merck Frosst Canada, Inc. | Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
AU702591B2 (en) * | 1994-12-21 | 1999-02-25 | Merck Frosst Canada Ltd. | Diaryl-2-(5H)-furanones as cox-2 inhibitors |
US5691374A (en) * | 1995-05-18 | 1997-11-25 | Merck Frosst Canada Inc. | Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors |
-
1997
- 1997-11-19 RO RO99-00572A patent/RO118566B1/ro unknown
- 1997-11-19 PL PL97373973A patent/PL194717B1/pl unknown
- 1997-11-19 UA UA99063447A patent/UA70294C2/uk unknown
- 1997-11-19 KR KR1019990704392A patent/KR20000053362A/ko not_active Application Discontinuation
- 1997-11-19 EP EP97949579A patent/EP0941080A2/fr not_active Withdrawn
- 1997-11-19 ID IDW990379A patent/ID21979A/id unknown
- 1997-11-19 AU AU72982/98A patent/AU730211B2/en not_active Ceased
- 1997-11-19 CZ CZ991768A patent/CZ176899A3/cs unknown
- 1997-11-19 SK SK599-99A patent/SK59999A3/sk unknown
- 1997-11-19 CA CA002270469A patent/CA2270469C/fr not_active Expired - Fee Related
- 1997-11-19 RU RU99112952/14A patent/RU2268716C2/ru not_active IP Right Cessation
- 1997-11-19 JP JP52396098A patent/JP2001505564A/ja not_active Withdrawn
- 1997-11-19 IL IL12960497A patent/IL129604A/en not_active IP Right Cessation
- 1997-11-19 NZ NZ335853A patent/NZ335853A/en not_active Application Discontinuation
- 1997-11-19 TR TR1999/01703T patent/TR199901703T2/xx unknown
- 1997-11-19 WO PCT/US1997/021489 patent/WO1998022101A2/fr not_active Application Discontinuation
- 1997-11-19 BR BR9713522A patent/BR9713522A/pt not_active Application Discontinuation
- 1997-11-19 CN CN97181368A patent/CN1247470A/zh active Pending
-
1999
- 1999-04-30 PL PL333370A patent/PL191793B1/pl unknown
- 1999-05-12 NO NO992309A patent/NO992309L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
UA70294C2 (en) | 2004-10-15 |
AU7298298A (en) | 1998-06-10 |
KR20000053362A (ko) | 2000-08-25 |
PL333370A1 (en) | 1999-12-06 |
NO992309D0 (no) | 1999-05-12 |
TR199901703T2 (xx) | 2000-07-21 |
RU2268716C2 (ru) | 2006-01-27 |
JP2001505564A (ja) | 2001-04-24 |
IL129604A0 (en) | 2000-02-29 |
ID21979A (id) | 1999-08-19 |
AU730211B2 (en) | 2001-03-01 |
RO118566B1 (ro) | 2003-07-30 |
NZ335853A (en) | 2002-02-01 |
CA2270469A1 (fr) | 1998-05-28 |
SK59999A3 (en) | 2000-01-18 |
CA2270469C (fr) | 2007-04-10 |
CZ176899A3 (cs) | 1999-10-13 |
EP0941080A2 (fr) | 1999-09-15 |
NO992309L (no) | 1999-05-12 |
CN1247470A (zh) | 2000-03-15 |
WO1998022101A3 (fr) | 1998-06-25 |
IL129604A (en) | 2004-08-31 |
PL194717B1 (pl) | 2007-06-29 |
WO1998022101A2 (fr) | 1998-05-28 |
PL191793B1 (pl) | 2006-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9713522A (pt) | Método de uso de inibidores da cicloxigenase-2 como agentes antiangiogênicos. | |
EA200100572A1 (ru) | Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии | |
AP9901674A0 (en) | Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders. | |
AU7321598A (en) | Use of cholinesterase inhibitors to treat disorders of attention | |
ATE301457T1 (de) | Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor | |
DE69725484D1 (de) | Vorrichtung zur Behandlung von Harninkontinenz | |
ES2172657T3 (es) | Inhibidores de trombina. | |
NO974680D0 (no) | Anvendelse av midler som frigir nitrogenholdig oksyd for behandling av impotens | |
BR9916567A (pt) | Combinações de inibidores do transporte ácido dabile ileal e derivados do ácido nicotìnico paraindicações cardiovasculares | |
EE9700267A (et) | a1L- agonistide kasutamine uriiniinkontinentsuse raviks | |
ATE193647T1 (de) | Di- und trivalente kleine moleküle als selektininhibitoren | |
DE69620691D1 (de) | Therapeutisches Mittel zur Behandlung der Hypercholesterinämie | |
MX9805290A (es) | Utilizacion de inhibidores de la actividad del acido retinoico para tratar las pieles sensibles y/o los daños agudos inducidos por las radiaciones ultravioleta. | |
WO1998005291A3 (fr) | Procede de traitement de l'arrieration mentale | |
ES2149448T3 (es) | Agentes terapeuticos y analiticos. | |
MXPA02004699A (es) | Derivados de acidos hidroxieicosatetraenoico modificados con cadena omega y metodos de su uso para el tratameinto del ojo reseco. | |
IL139144A0 (en) | Mycobacterial inhibitors | |
NO963989L (no) | Hypokolesterolemiske-, antiatherosklerotiske- og hypotriglyceridemiske mercaptoacetylamidderivater | |
ATA93695A (de) | Mittel zur behandlung von strahlenschäden | |
ATE202089T1 (de) | Chinolonderivat zur behandlung der harnincontinenz | |
HUP0001100A2 (hu) | Szklerózis elleni hatású specifikus zsiradék | |
MY140504A (en) | Statin-mmp inhibitor combinations | |
EE9800166A (et) | Meetod ja seade lõhnaaine lisamiseks | |
NO963988L (no) | Hypokolesterolemiske-, antiatherosklerotiske-, og hypotriglyceridemiske mercaptoacetylamidderivater | |
ITMI950115A0 (it) | Dispositivo atto al trattamento delle immondizie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA ( ART. 8O COMBINADO COM ART. 13 DA LPI ). |
|
B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DE INT.CL: A61K 31/00, A61K 31/45, A61P 35/00, A61P 15/00 Ipc: A61K 31/00 (2007.10), A61K 31/45 (2007.10), A61K 3 |